We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+3.33%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$22.8M
AUM Growth
+$681K
Cap. Flow
-$442M
Cap. Flow %
-1,939.41%
Top 10 Hldgs %
14.43%
Holding
3,409
New
162
Increased
850
Reduced
1,040
Closed
145

Top Buys

Rank Stock Value
1
EA icon
Electronic Arts
EA
+$114M
2
CDNS icon
Cadence Design Systems
CDNS
+$112M
3
FTNT icon
Fortinet
FTNT
+$81.7M
4
CMI icon
Cummins
CMI
+$68.3M
5
XLNX
Xilinx Inc
XLNX
+$58.6M

Sector Composition

Rank Sector Weight
1 Technology 15.74%
2 Healthcare 13%
3 Financials 12.4%
4 Industrials 10.58%
5 Consumer Discretionary 7.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DUK icon
376
Duke Energy
DUK
$102B
$7.07K 0.03%
80,084
-12,616
-14% -$1.12M
MDY icon
377
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$27B
$7K 0.03%
19,729
+567
+3% +$198K
ORLY icon
378
O'Reilly Automotive
ORLY
$72.4B
$6.95K 0.03%
282,510
-81,255
-22% -$2.06M
QQQ icon
379
Invesco QQQ Trust
QQQ
$455B
$6.9K 0.03%
36,945
-12,642
-25% -$2.33M
XLE icon
380
State Street Energy Select Sector SPDR ETF
XLE
$39.5B
$6.84K 0.03%
214,668
-21,810
-9% -$698K
BP icon
381
BP
BP
$113B
$6.81K 0.03%
166,204
+29,267
+21% +$1.23M
IWN icon
382
iShares Russell 2000 Value ETF
IWN
$14.4B
$6.8K 0.03%
56,448
+29,643
+111% +$3.58M
DHR icon
383
Danaher
DHR
$135B
$6.72K 0.03%
53,016
+2,436
+5% +$288K
AZN icon
384
AstraZeneca
AZN
$263B
$6.71K 0.03%
81,331
-1,222
-1% -$95.8K
UPM
385
DELISTED
UPM-KYMMRME ADR (REPR ORD SHS)
UPM
$6.68K 0.03%
250,881
+134
+0.1% +$4
TTE icon
386
TotalEnergies
TTE
$193B
$6.65K 0.03%
119,287
-9,745
-8% -$532K
AMED
387
DELISTED
Amedisys
AMED
$6.56K 0.03%
54,070
-9,884
-15% -$1.17M
AZ
388
DELISTED
Allianz Se Sponsored Adr Repstg 1/10 Ord Sh
AZ
$6.54K 0.03%
270,957
+1,266
+0.5% +$31
UN
389
DELISTED
Unilever NV New York Registry Shares
UN
$6.54K 0.03%
107,725
+11,869
+12% +$710K
DE icon
390
Deere & Co
DE
$170B
$6.42K 0.03%
38,779
+602
+2% +$93.7K
CINF icon
391
Cincinnati Financial
CINF
$28.3B
$6.4K 0.03%
61,758
+9,515
+18% +$913K
ORI icon
392
Old Republic International
ORI
$10.3B
$6.4K 0.03%
286,125
+50
+0% +$1.1K
VO icon
393
Vanguard Mid-Cap ETF
VO
$106B
$6.29K 0.03%
150,644
+1,568
+1% +$64.2K
MOH icon
394
Molina Healthcare
MOH
$10.3B
$6.12K 0.03%
42,760
-7,140
-14% -$978K
GS icon
395
Goldman Sachs
GS
$313B
$6.07K 0.03%
29,651
+6,304
+27% +$1.25M
MAGN
396
Magnera Corp
MAGN
$488M
$6.04K 0.03%
27,520
VNDA icon
397
Vanda Pharmaceuticals
VNDA
$312M
$6.01K 0.03%
426,726
-1,381,475
-76% -$22M
SLM icon
398
SLM Corp
SLM
$4.57B
$5.84K 0.03%
601,241
+34,227
+6% +$339K
PAA icon
399
Plains All American Pipeline
PAA
$17.4B
$5.74K 0.03%
235,819
+49,476
+27% +$1.18M
EPR icon
400
EPR Properties
EPR
$4.86B
$5.69K 0.03%
76,258

Similar funds

Glenmede Trust's Q2 2019 Portfolio in Review

As of Q2 2019, Glenmede Trust held 3,409 positions worth $22.8M, up 3.1% from $22.1M the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Glenmede Trust withdrew a net $442M in Q2 2019, closing 145 positions and reducing 1,040 holdings. Its most notable exit was Sinclair Inc, an estimated $23.5K position sold in full.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Glenmede Trust opened a new position in Dow Inc worth $29.7K.

  • Glenmede Trust's largest Q2 2019 buy was Dow Inc: 602,067 shares worth $29.7K.
  • Glenmede Trust added most to Electronic Arts in Q2 2019, an estimated $114M increase.
  • Glenmede Trust's biggest Q2 2019 reduction was Cognizant, cutting an estimated $93.3M.
  • Glenmede Trust fully exited Sinclair Inc in Q2 2019, selling an estimated $23.5K.
  • Glenmede Trust's ten largest holdings make up 14% of its $22.8M portfolio in Q2 2019.
  • Glenmede Trust opened 162 new positions and closed 145 in Q2 2019.
  • Glenmede Trust's portfolio value rose 3.1% quarter-over-quarter to $22.8M.

Based on Glenmede Trust's 13F filing for Q2 2019, filed 13 Aug 2019.